The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it was first introduced in 1950. Proponents of drug price regulation argue that drug makers raise prices to benefit the value of their stock and invest little of their profits in the development and research of new drugs. Opponents of regulation argue that consumers rely on drug companies to develop new drugs and limiting prices will prevent new lifesaving drugs from being developed.
91% Yes |
9% No |
87% Yes |
6% No |
2% Yes, and we should socialise medicine and healthcare |
1% No, limiting drug prices would also limit the investment in research and development into new life-saving drugs |
2% Yes, and the government should regulate the price of all prescription drugs |
1% No, but shorten the lifespan of drug patents |
0% No, and the government should never regulate prices of private businesses |
See how support for each position on “Drug Price Regulation” has changed over time for 243k Australia voters.
Loading data...
Loading chart...
See how importance of “Drug Price Regulation” has changed over time for 243k Australia voters.
Loading data...
Loading chart...
Unique answers from Australia users whose views extended beyond the provided choices.
@98PXPCQ1yr1Y
The drug of Australia sauce pan and saving treatment inc
@933W82X2yrs2Y
I’m unsure on this question
@8MDQD4J3yrs3Y
No, but the government should provide a capped amount for each drug to prevent Pharmaceutical companies from massively inflating drug prices.
@8HTJ7D24yrs4Y
No, the government should subsidise
@8DHFL2N4yrs4Y
Yes, but through subsidies rather than straight up regulation.
@92LTWLD2yrs2Y
This question confuses me.
Explore other topics that are important to Australia voters.
